Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:699-709

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakagawa, H.
Right arrow Articles by Jackman, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakagawa, H.
Right arrow Articles by Jackman, W. M.
Related Collections
Right arrow Electrophysiology
Right arrow Ablation/ICD/surgery
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Cardiac development

(Circulation. 2001;103:699.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Characterization of Reentrant Circuit in Macroreentrant Right Atrial Tachycardia After Surgical Repair of Congenital Heart Disease

Isolated Channels Between Scars Allow "Focal" Ablation

Hiroshi Nakagawa, MD, PhD; Nayyar Shah, MD; Kagari Matsudaira, MD; Edward Overholt, MD; Krishnaswamy Chandrasekaran, MD; Karen J. Beckman, MD; Peter Spector, MD; James D. Calame, RN; Arun Rao, MD; Can Hasdemir, MD; Kenichiro Otomo, MD; Zulu Wang, MD; Ralph Lazzara, MD; Warren M. Jackman, MD

From the Cardiac Arrhythmia Research Institute, University of Oklahoma Health Sciences Center, Oklahoma City.

Correspondence to Hiroshi Nakagawa, MD, PhD, Cardiac Arrhythmia Research Institute, 1200 Everett Dr (TUH-6E 103), Oklahoma City, OK 73104. E-mail hiroshi-nakagawa{at}ouhsc.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—The purpose of this study was to characterize the circuit of macroreentrant right atrial tachycardia (MacroAT) in patients after surgical repair of congenital heart disease (SR-CHD).

Methods and Results—Sixteen patients with atrial tachycardia (AT) after SR-CHD were studied (atrial septal defect in 6, tetralogy of Fallot in 4, and Fontan procedure in 6). Electroanatomic right atrial maps were obtained during 15 MacroATs in 13 patients, focal AT in 1 patient, and atrial pacing in 2 patients without stable AT. A large area of low bipolar voltage (<=0.5 mV) involved most of the free wall in all patients and contained 2 to 7 dense scars or lines of double potentials, forming 29 narrow channels (width <=2.7 cm) between scars in all but 1 patient, who had a single scar and only focal AT. All 15 MacroATs were propagated through narrow channels. Ablation within the channel eliminated all 15 MacroATs with 1 to 3 (median 1) radiofrequency applications. Ablation was performed in 9 other channels identified during MacroAT (5 patients) and in 5 channels identified during atrial pacing (2 patients). Conduction block was obtained across 28 of 29 channels. After ablation, reproducible sustained right AT was not induced in any patient. During follow-up (median 13.5 months), new MacroATs, atrial fibrillation, or palpitations occurred in 3 of 16 patients.

Conclusions—MacroAT after SR-CHD requires a large area of low voltage containing >=2 scars forming narrow channels. Ablation within the channels eliminates MacroAT.


Key Words: catheter ablation • heart defects, congenital • atrial flutter • Fontan procedure


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Macroreentrant right atrial tachycardia (MacroAT) is a late complication that occurs after the surgical repair of congenital heart disease.1 2 3 4 Catheter ablation has been useful in only selected patients1 2 3 4 because of the presence of multiple or unstable (unmappable) atrial tachycardias (ATs).

Two approaches have been proposed for ablation. In the first approach, an isolated diastolic atrial potential is identified during MacroAT, and entrainment pacing is used to confirm participation within the reentrant circuit.1 4 The second approach is based on the concept that MacroAT results from reentry around the atriotomy scar. A linear lesion is created between the atriotomy scar and an anatomic barrier (tricuspid annulus or inferior vena cava [IVC] or superior vena cava [SVC]).2 3 These approaches ablated at least 1 tachycardia in 73% to 93% of patients.1 2 3 However, tachycardia recurred in 33% to 53% of patients after acute success.2 3 4 We hypothesized that the high recurrence after ablation might be related to incomplete identification of all possible reentrant circuits.

The purpose of the present study was to localize all components of MacroAT reentrant circuits in patients after the surgical repair of congenital heart disease by use of an electroanatomic mapping system5 and to identify and eliminate other potential reentrant circuits that might be related to otherwise unmappable tachycardias.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
All patients referred for ablation of AT after the surgical repair of congenital heart disease were included. Patients were not excluded for multiple ATs by history or at electrophysiological study or for noninducibility of stable sustained AT. Patients with only typical atrial flutter (AFL, reentry around the tricuspid annulus) were excluded.

Electrophysiological Study
Electrophysiological study was performed with patients under general anesthesia (propofol). Multielectrode catheters were inserted transvenously and positioned in the coronary sinus, in the high right atrium, around the tricuspid annulus, and (except Fontan patients) in the His bundle region and right ventricle. Right atrial mapping was performed during each sustained AT by use of a quadripolar electrode catheter with 0.5- to 5- to 2-mm spacing and a 4-mm tip electrode (Navistar, Biosense Webster). The average distance between mapped sites was {approx}5 mm (2 to 4 mm in areas of interest).

Electroanatomic Mapping System
The electroanatomic mapping system (CARTO, Biosense Webster) has been described previously.5 With use of a magnetic sensor, the system displays the location of the mapping/ablation catheter relative to the location of a reference sensor taped to the posterior chest (accuracy <=1 mm).5

A coronary sinus or right atrial electrogram was used as a timing reference. A window of time, equal to the tachycardia cycle length, was established around the reference activation time. The activation time at each site was displayed in color relative to its timing within the window (earliest, red; latest, purple). The voltage of the bipolar atrial potential recorded at each site was also displayed in color (lowest, red; greatest, purple). Areas with no atrial potential distinguishable from noise (generally <=0.03 mV) were considered dense scars and were displayed in gray.

Definition of MacroAT
MacroAT was defined as follows: (1) continuous sequence of activation, with earliest activation (red) adjacent to latest activation (purple), and (2) range of activation times equal to the tachycardia cycle length.

A focal pattern of activation was defined as follows: (1) radiation in all directions from a single site of earliest activation and (2) range of activation times less than the tachycardia cycle length.

Ablation
Ablation was directed at the site of earliest activation for focal AT and directed at isolated channels for MacroAT. Radiofrequency (RF) current was initiated at {approx}10 W, was increased until the impedance decreased 3 to 5{Omega}, and was maintained until the unipolar atrial potential recorded from the ablation electrode decreased by 80% or split into 2 small potentials, indicating transmural necrosis. The catheter was held stationary ({approx}70%) or was dragged across the channel ({approx}30%).

Conduction block across the channel was verified by pacing close to the ablation line and by demonstration of marked delay and reversal in the direction of activation on the opposite side of the ablation line. Programmed stimulation was repeated to induce the same or another AT.

When AT was nonsustained, variable in activation sequence, or nonreinducible (unmappable AT), mapping was performed during atrial pacing to identify the channels between scars. Ablation was performed across as many narrow (<3.0 cm in width) channels as possible.

Postablation Management
Transesophageal echocardiography was performed within 24 hours after ablation. Patients with repair of an atrial septal defect (ASD) or tetralogy of Fallot (ToF) received aspirin (325 mg/d) for 6 weeks. Patients with a Fontan procedure or history of atrial fibrillation received warfarin. The patients were discharged on no antiarrhythmic drugs.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Study Population
The study population consisted of 16 patients (Table 1Down). Six had repair of secundum ASD; 4 had correction of ToF; and 6 had the Fontan procedure.


View this table:
[in this window]
[in a new window]
 
Table 1. Study Population

AT, present for 1 to 13 years, was paroxysmal in 10 patients and incessant in 6. Multiple ATs had been documented in 12 (75%) patients. AT was unresponsive to 2 to 6 (median 3) antiarrhythmic drugs in all patients, including amiodarone in 9 patients. Nine (56%) patients had prior unsuccessful ablation procedures for AT. Six patients had previously undergone ablation of AFL.

Electrophysiological Study
Sixty-nine ATs (1 to 7 per patient, median 5) were present incessantly (6 ATs) or were induced by programmed stimulation (63 ATs, Figure 1Down). Four tachycardias originated from the left atrium, and 65 originated from the right atrium. Seventeen right ATs in 14 of the 16 patients were sustained and reproducible, allowing a complete right atrial map during tachycardia. Fifteen of 17 ATs (13 of 14 patients) exhibited a macroreentrant activation pattern, and 2 ATs (2 patients) exhibited focal activation originating at the crista terminalis.



View larger version (40K):
[in this window]
[in a new window]
 
Figure 1. Ablation results. RA indicates right atrial; LA, left atrial; and Tach, tachycardia.

In the remaining 2 patients (Nos. 6 and 16, Table 1Up) with unmappable AT, a right atrial map was obtained during atrial pacing to localize potential arrhythmogenic channels.

ASD Patients
A complete right atrial map (182 to 318 points) was obtained during 5 ATs in 5 of 6 ASD patients (Nos. 1 to 5) and was consistent with MacroAT in all (Figure 2Down). The circuit was located within a large area of low voltage (bipolar voltage <=0.5 mV) involving the free wall and extending to the septum (median height 7.8 cm, width 10.3 cm; Table 2Down) in all patients. The low-voltage area contained many sites exhibiting fragmented or double atrial potentials. It also contained 2 adjacent areas with no bipolar atrial potential distinguishable from noise (dense scars) in 2 patients (Figures 2Down and 3Down) or a narrow scar (line of double potentials) adjacent to a dense scar in 3 patients (Figures 4Down and 5Down). The dense scars or areas of double potentials measured 1.0 to 4.9 (median 2.4) cm in length and 0.5 to 4.4 (median 1.6) cm in width. The lower scar appeared continuous with the IVC in all 5 patients. The upper scar was larger than the lower scar and located at the mid free wall in 4 of 5 patients (Figure 3Down). The MacroAT circuit propagated around the upper scar and through the narrow channel between the 2 adjacent scars in all 5 patients. The channels were {approx}0.7 to 1.6 cm in width and 0.8 to 3.4 cm in length (Table 2Down).



View larger version (54K):
[in this window]
[in a new window]
 
Figure 2. A, Activation map during MacroAT in ASD patient 1 shows continuous activation around smaller upper dense scar (gray area with gray tags) and line of double potentials (pink tags) and through channel (width 1.6 cm) between scars. Larger lower scar extends to IVC. Three stationary RF applications across channel (brown tags) terminated MacroAT. B, Bipolar voltage map shows large area of low voltage (red and orange) containing 2 dense scars with narrow channel.


View this table:
[in this window]
[in a new window]
 
Table 2. Mapping and Ablation in Study Patients



View larger version (54K):
[in this window]
[in a new window]
 
Figure 3. Map of MacroAT in ASD patient 2 illustrating long channel (length 3.4 cm) between upper and lower dense scars. Part of channel is bounded by 2 lines of block (pink tags) extending from upper dense scar. Lower scar is continuous with IVC. Entrainment at site 1 (just outside channel exit), which exhibited a small middiastolic potential, produced concealed fusion and PPI=TCL. Ablation at site 1 (RF1) failed to terminate tachycardia. Entrainment at site 2 (outside channel entrance) also produced concealed fusion and PPI=TCL. Entrainment at site 3 produced concealed fusion with PPI=TCL plus 146 ms (blind alley). RF2 within channel terminated tachycardia in 2 seconds, even though pacing at this site failed to capture. RAO indicates right anterior oblique.



View larger version (68K):
[in this window]
[in a new window]
 
Figure 4. Comparison of voltage abnormality between septum and free wall in ASD patient 5. A, Activation map during MacroAT shows propagation through channel between dense scar (continuous with IVC) and lines of double potentials (pink tags). Tachycardia was terminated by linear RF application (8 mm) across channel near entrance (RF1). One additional RF application was delivered to that channel. Two other channels (between lines of double potentials) were identified in this map and were ablated (brown dots in panel B) during sinus rhythm, eliminating inducibility of 6 remaining nonsustained tachycardias. B and C, Voltage map before ablation is shown. Compared with the free wall (panel B), voltage on the septum was less depressed, with fewer abnormal potentials (pink and green tags). PA indicates posteroanterior.



View larger version (71K):
[in this window]
[in a new window]
 
Figure 5. Schematic representation of activation and voltage maps for patients (Pts) with ASD (A), ToF (B), and Fontan procedure (C). Maps in Pts 6 and 16 were obtained during atrial pacing. Other maps were obtained during MacroAT. Orange represents low-voltage area, gray represents dense scar, and white indicates lines of double potentials. Yellow stars indicate ablation sites that terminated MacroAT. Green stars represent ablation sites within other channels identified from original map. In Pt 3, MacroAT during initial procedure (solid black lines) was eliminated by ablation at upper yellow star. Lower yellow star shows ablation site of second MacroAT (dotted lines) 7 months later. Blue dots (Pts 10 and 14) indicate ablation sites of focal tachycardia.

All 5 MacroATs were terminated by 1 to 3 (median 2) stationary (Figures 2Up and 3Up) or dragging (Figure 4Up) RF applications applied within an isolated channel. After ablation of the single channel, the original AT was not induced in any of the patients. No other AT was induced in 3 of 5 patients (Nos. 1, 2, and 4). In patient 3, 1 episode of another AT was induced. This tachycardia could not be reinduced, preventing mapping and ablation. Two left ATs were also induced in this patient. Neither left atrial mapping nor ablation was attempted. In patient 5, 6 other ATs were induced that were nonsustained or not reinduced. After ablation across 2 other channels selected from the initial map (Figures 4Up and 5AUp), no AT was induced.

In the remaining patient (No. 6), entrainment pacing performed before completion of the map terminated the MacroAT. The original tachycardia could not be reinduced. Stimulation induced multiple episodes of 3 other nonsustained ATs. A map was then obtained during atrial pacing, revealing a large area of low voltage containing 2 dense scars forming a channel 1.5 cm in width (Figure 5AUp). Ablation produced block across the channel. No AT was induced after ablation.

Eight channels were targeted in the 6 ASD patients. Block was confirmed in 7 patients and not tested in 1 (Table 2Up).

The septum did not participate in the circuit in any of the 5 mapped MacroATs. Although reduced, the septal voltage was greater than the free wall voltage in all 6 patients (Figure 4Up). The septum contained a small dense scar or double potentials in only 2 patients (Nos. 3 and 5). The closest area of block to these small scars was 4.4 and 3.7 cm. These wide channels were not associated with MacroAT, and ablation was not attempted.

ToF Patients
A map (175 to 223 points) was obtained during sustained AT in all 4 ToF patients. Three (Nos. 7 to 9) had macroreentry confined to the free wall within a large area of low voltage (Table 2Up), containing 2 dense scars or a dense scar and a line of double potentials (Figure 5BUp). The lower scar was continuous with the IVC in 2 patients, and there was a line of double potentials (block) between the lower scar and IVC in 1 patient (Figure 6Down). In all 3 patients, reentry was propagated through the channel (0.7 to 1.1 cm wide) and around the upper scar. Only 1 to 3 RF applications terminated tachycardia, produced block across the channels, and prevented reinduction of any sustained AT.



View larger version (62K):
[in this window]
[in a new window]
 
Figure 6. Short conduction time across channel during MacroAT in ToF patient 7. Reentry propagates around upper dense scar and line of double potentials (upper pink tags) and through channel (width 0.7 cm) between upper and lower dense scars. Entrainment at channel entrance (site 1) and exit (site 2) produced concealed fusion and PPI=TCL. Time across channel (from site 1 to site 2) was 30 ms, only 11% of TCL. Note line of double potentials extending from lower dense scar to IVC. One stationary RF application within channel (brown tag) terminated tachycardia at 2.2 seconds. RAO indicates right anterior oblique.

The fourth patient (No. 10) had only focal AT (crista terminalis). One RF application eliminated the AT. The voltage map showed a narrower area of low voltage (width 3.2 cm), containing a single scar extending to the IVC (no channel).

Fontan Patients
In the 6 Fontan patients, maps containing 257 to 419 (median 321) points were obtained during 2 MacroATs (2 patients), during 1 MacroAT (3 patients), and during atrial pacing (1 patient). The maps demonstrated very large right atria with large areas of low voltage involving the free wall and septum, containing 3 to 7 (median 5.5) dense scars or lines of double potentials (Table 2Up). The size and location of the scars varied among patients, resulting in different reentrant circuits (Figure 5CUp).

In 2 patients (Nos. 11 and 14), the scars were continuous with SVC or IVC, producing reentry around the right atrium in the transverse plane (Figure 7Down). The other 4 patients had 3 to 6 channels and 3 to 7 MacroATs. All channels were identified in the first map obtained either during a tachycardia (patients 12, 13, and 15) or atrial pacing (patient 16). For example, in patient 12, the first map obtained during a MacroAT showed a small circuit (2-cm diameter) incorporating 2 channels plus a third uninvolved channel (Figure 8Down). The voltage throughout the circuit was extremely low (0.04 to 0.06 mV), which may explain the long cycle length (435 ms). A single stationary RF application within 1 channel terminated the tachycardia. One additional application was delivered within the same channel (RF2, Figure 8BDown). Three applications were delivered across the second channel, guided by the initial map (RF3 to RF5). The third channel was subsequently shown to produce another MacroAT, which was terminated by a single linear (1.0-cm length) RF application within the channel (RF6), followed by an additional application (RF7).



View larger version (66K):
[in this window]
[in a new window]
 
Figure 7. A, MacroAT circuit around right atrium in transverse plane (Fontan patient 11) is shown. B, Entrainment at site 1 (septal channel) and site 2 (free-wall channel) produced concealed fusion and PPI=TCL, confirming that both channels were within circuit. One RF application in free-wall channel terminated tachycardia. R indicates right; L, left; TV, tricuspid valve; PA, posteroanterior; and AP, anteroposterior.



View larger version (47K):
[in this window]
[in a new window]
 
Figure 8. Small MacroAT circuit with low-amplitude atrial potentials and long cycle length (Fontan patient 12). A, MacroAT was propagated around small dense scar within area constrained by upper and lower dense scars continuous with SVC and IVC. Although circuit length was only 8 cm, cycle length was 435 ms. B, Voltage map shows extremely low bipolar voltage involving most of free wall. C, Bipolar electrogram (ABL, 30 to 500 Hz) at RF1 site shows small potential (0.06 mV, arrow), simulating dense scar. This potential was within P wave (315 ms or 72% of TCL before onset of next P wave). D, RF1 terminated MacroAT after 2.2 seconds.

At least 6 channels were identified from a map (367 points) obtained during atrial pacing in patient 16, who had multiple ATs that were unmappable because of the frequently changing activation sequence. Four of 6 channels were selected for ablation (Figure 5CUp). Block was obtained across 3 of the 4 channels. Block was not obtained across the fourth channel with the highest voltage (1.48 mV), consistent with thicker atrial myocardium.

Block was obtained across 19 of 20 channels in the 6 Fontan patients (Figure 9Down, Table 2Up). After ablation, only 6 of 33 ATs were induced in 3 of 6 patients. These tachycardias were nonsustained (3 ATs), left atrial (2 ATs), or nonreproducible (1 AT).



View larger version (75K):
[in this window]
[in a new window]
 
Figure 9. Confirmation of block across 2 channels after ablation (Fontan patient 15). A, Map during MacroAT shows propagation through 2 channels close to RA–pulmonary artery connection. RF1 in channel 1 terminated tachycardia in 5 seconds. Two additional RF applications (RF2 and RF3) were delivered across channel 1, and 3 RF applications (RF4 to RF6) were delivered across channel 2 during sinus rhythm. B, Map after ablation during atrial pacing (cycle length 520 ms) from above the 2 ablation lines (yellow tag) shows propagation around ablation lines (brown tags), confirming block across the 2 channels.

Entrainment Pacing
Entrainment pacing was performed in the first 3 ASD patients, 2 ToF patients, and 1 Fontan patient. Entrainment confirmed the sites suspected to be inside or outside the reentrant circuit on the basis of the activation map (Figures 2Up, 3Up, 6Up, and 7Up). Many sites within the circuit, but outside the isolated channel ("outer loop" site), exhibited a diastolic potential, entrainment with concealed fusion (same P wave and activation sequence), and a postpacing interval equal to the tachycardia cycle length (PPI=TCL). Ablation at one such site failed to terminate tachycardia, whereas 1 application of RF current delivered within the channel (identified from the activation map) terminated the tachycardia, even though pacing at that site failed to capture. (Figure 3Up).

Because entrainment provided only confirmatory information and could terminate the tachycardia before ablation, entrainment was not used in the last 9 patients. The number of RF applications required to terminate MacroAT was not different between the groups using and not using entrainment, 1 to 3 (median 1.5) versus 1 to 3 (median 1) applications.

Characteristics of Channel Potentials
The timing of the atrial potential at the 15 ablation sites terminating MacroAT was distributed throughout the tachycardia cycle length (Figure 10Down). The electrogram exhibited single (6 sites), double (5 sites), or fragmented (4 sites) atrial potentials. The bipolar atrial potential amplitude ranged from 0.05 to 0.41 mV. The amplitude was extremely low (<=0.1 mV), mimicking dense scar, at 7 of the 15 sites (Figure 8CUp).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 10. Atrial potential characteristics at ablation sites terminating 15 MacroATs.

Ablation of AFL
AFL was also ablated in 12 of 16 patients, 7 in this procedure and 5 in a prior procedure.

Follow-Up
The 16 patients were followed up for 1 to 29 (median 13.5) months after ablation. Fifteen received no antiarrhythmic drug. Patient 1 eventually received sotalol to suppress ventricular tachycardia. Sotalol has previously failed to prevent MacroAT.

All 16 patients have had a significant improvement in symptoms. Atrial tachyarrhythmia recurred in 3 (19%) of 16 patients. One ASD patient (No. 3) had 3 episodes of AT (lasting 6 hours) over 7 months. At repeat study, a new MacroAT with a longer cycle length (330 versus 208 ms) was induced. The map demonstrated reentry around a large scar (formed by fusion of the original upper and lower scars) and through a narrow channel between the fused scar and IVC (Figure 5AUp, patient 3, dotted line). The conduction time through the channel was 155 ms, simulating block during the first ablation procedure. Tachycardia was eliminated by a single RF application within the new channel. Mapping during atrial pacing after ablation confirmed block across the new and previous channels.

One Fontan patient (No. 12) had a single episode of atrial fibrillation 12.5 months after ablation. Electrophysiological study failed to induce any of the original ATs. Mapping confirmed block across the 3 original channels. Programmed stimulation induced a focal AT originating in the posterior right atrium, eliminated by 2 RF applications.

Another Fontan patient (No. 13) had a single episode of palpitations lasting 15 minutes and several other episodes of palpitations lasting <15 seconds. None of the episodes were recorded.

Complications
There were no complications.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Substrate for MacroAT
The entire reentrant circuit was identified in the 15 sustained reproducible MacroATs. All circuits were located within a large area of low voltage (depressed conduction) containing a narrow channel (<=2.7 cm in width) between 2 close dense or thin scars (lines of block). The lines of block (double potentials) during tachycardia were also recorded during atrial pacing (long cycle length) after ablation, suggesting fixed anatomic block rather than functional block. Similarly, areas with no atrial potential during tachycardia exhibited no atrial potential during pacing.

The arrhythmogenic substrate was found in the free wall and not the septum, even in patients with ASD closure. The cause of the large area of low voltage ("atrial myopathy") is unclear. Possible explanations include interruption of arterial supply and insufficient protection during cardioplegia. The multiple dense scars may result from the atriotomy, venous cannulation sites, conduit sites, and other surgical trauma.

The single patient with only focal AT had a narrower area of low voltage and a single dense scar extending to IVC, with no channel through the scar (no channel–no macroreentry).

Focal Ablation Within an Isolated Channel
Each MacroAT used at least 1 narrow channel, allowing a single point or very short linear (focal) ablation. The 15 mapped MacroATs were terminated by 1 to 3 (median 1) stationary or short dragging RF applications delivered within an isolated channel.

Only 1 isolated channel was identified in 7 of 9 ASD and ToF patients. In contrast, 5 of 6 Fontan patients had multiple channels and macroreentrant circuits. Because all channels could be identified from a single high-density map (2- to 5-mm spacing), the strategy used in later patients was to obtain 1 complete map during a stable MacroAT. One channel was ablated, terminating the tachycardia. Guided by the initial map, as many other channels as possible were ablated before attempting to reinduce tachycardia. This approach reduced the number of maps required. The ability to identify the channels from a map during atrial pacing allowed the ablation of multiple channels in 2 patients with unmappable ATs. The lower success rate for ablation in Fontan patients in previous studies may relate to the inability to identify all of the channels by use of conventional mapping techniques.1 2 3 4

The atrial potential at 7 of the 15 ablation sites terminating MacroAT was extremely small (<=0.1 mV), mimicking dense scar (Figures 8Up and 10Up). In the present study, the maps included every distinguishable bipolar potential. Many of the channels between 2 scars would have been obscured (displayed as a single scar) if the scar had been defined by an arbitrary voltage criterion (ie, <=0.1 mV).

The combination of a diastolic potential and entrainment pacing showing concealed fusion with PPI=TCL has been considered to identify a "protected isthmus" within the circuit (ideal ablation site).1 2 In the present study, potentials within channels occurred throughout the atrial cycle, not just in diastole. In addition, because most of the cycle length involved conduction in broad low-voltage areas, many sites outside of channels exhibited diastolic potentials and concealed entrainment (because the paced impulse exited the low-voltage area in the same region) with PPI=TCL (Figure 3Up). Neither electrogram morphology, timing, nor entrainment differentiated between sites within or outside a narrow channel. Entrainment pacing may also terminate or change the tachycardia and therefore was not helpful in the presence of a high-density map.

After ablation of the channels, reproducible sustained right AT was not induced by programmed stimulation in any of the 15 patients. This compares favorably with the 73% to 93% acute success rate (defined as elimination of at least 1 AT) with the use of conventional catheter mapping techniques.1 2 3 More important, confirmed sustained MacroAT recurred during follow-up in only 1 patient, in whom a slowly conducting channel was initially mistaken as a block. In previous studies using conventional mapping techniques, AT recurred in 33% to 53% of patients with acute success.2 3 4

AT has not recurred in either of the 2 patients in whom ablation was performed in channels identified from a map during atrial pacing, suggesting that a high-resolution map during atrial pacing may be as useful as a map during MacroAT.

Limitations of the Study
The principal limitation of the present study was the time required to obtain high-density maps by use of this point-by-point technique. This limitation is mitigated somewhat by the ability to identify all channels from a single map during 1 tachycardia or pacing.


*    Footnotes
 
Drs Nakagawa and Jackman serve as consultants to Biosense Webster.

Received July 19, 2000; revision received September 22, 2000; accepted September 26, 2000.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Triedman JK, Saul P, Weindling SN, et al. Radiofrequency ablation of intra-atrial reentrant tachycardia after surgical palliation of congenital heart disease. Circulation. 1995;91:707–714.[Abstract/Free Full Text]

2. Kalman JM, VanHare GF, Olgin JE, et L. Ablation of "incisional" reentrant atrial tachycardia complication surgery for congenital heart disease. Circulation. 1996;93:502–512.[Abstract/Free Full Text]

3. Baker BM, Lindsay BD, Bromberg B, et al. Catheter ablation of intraatrial reentrant tachycardias resulting from previous atrial surgery: location and transecting the critical isthmus. J Am Coll Cardiol. 1996;28:411–417.[Abstract]

4. Triedman JK, Bergau FD, Saul P, et al. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 1997;30:1032–1038.[Abstract]

5. Ben-Haim SA, Osadchy D, Schuster I, et al. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med. 1996;2:1393–1395. [Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
Circ Arrhythm ElectrophysiolHome page
N. M.S. de Groot, P. Lukac, N. A. Blom, J. P. van Kuijk, A. K. Pedersen, P. S. Hansen, E. Delacretaz, and M. J. Schalij
Long-Term Outcome of Ablative Therapy of Postoperative Supraventricular Tachycardias in Patients With Univentricular Heart: A European Multicenter Study
Circ Arrhythm Electrophysiol, June 1, 2009; 2(3): 242 - 248.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Peichl, J. Kautzner, and R. Gebauer
Ablation of atrial tachycardias after correction of complex congenital heart diseases: utility of intracardiac echocardiography
Europace, January 1, 2009; 11(1): 48 - 53.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
J.#x.;n. Farré, H. J.J. Wellens, J.#x. M. Rubio, and J. Benezet
CHAPTER 28 Supraventricular Tachycardias
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al.
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., December 2, 2008; 52(23): e143 - e263.
[Full Text] [PDF]


Home page
CirculationHome page
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al.
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation, December 2, 2008; 118(23): e714 - e833.
[Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
K. Yokoyama, H. Nakagawa, D. C. Shah, H. Lambert, G. Leo, N. Aeby, A. Ikeda, J. V. Pitha, T. Sharma, R. Lazzara, et al.
Novel Contact Force Sensor Incorporated in Irrigated Radiofrequency Ablation Catheter Predicts Lesion Size and Incidence of Steam Pop and Thrombus
Circ Arrhythm Electrophysiol, December 1, 2008; 1(5): 354 - 362.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. Knackstedt, P. Schauerte, and P. Kirchhof
Electro-anatomic mapping systems in arrhythmias
Europace, November 1, 2008; 10(suppl_3): iii28 - iii34.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
A. M. Patel, A. d'Avila, P. Neuzil, S. J. Kim, MSEE, T. Mela, J. P. Singh, J. N. Ruskin, and V. Y. Reddy
Atrial Tachycardia After Ablation of Persistent Atrial Fibrillation: Identification of the Critical Isthmus With a Combination of Multielectrode Activation Mapping and Targeted Entrainment Mapping
Circ Arrhythm Electrophysiol, April 1, 2008; 1(1): 14 - 22.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
R. E. Eckart and L. M. Epstein
Interventional Therapy for Atrial and Ventricular Arrhythmias
Card. Surg. Adult, January 1, 2008; 3(2008): 1357 - 1374.
[Full Text]


Home page
CirculationHome page
G. F. Van Hare
Substrate Mapping and Catheter Ablation of Ventricular Tachycardia after Right Ventriculotomy
Circulation, November 13, 2007; 116(20): 2236 - 2237.
[Full Text] [PDF]


Home page
CirculationHome page
E. P. Walsh
Interventional Electrophysiology in Patients With Congenital Heart Disease
Circulation, June 26, 2007; 115(25): 3224 - 3234.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Lukac, V. E. Hjortdal, A. K. Pedersen, P. T. Mortensen, H. K. Jensen, and P. S. Hansen
Prevention of Atrial Flutter With Cryoablation May Be Proarrhythmogenic
Ann. Thorac. Surg., May 1, 2007; 83(5): 1717 - 1723.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. J. Kanter
The Fontan Right Atrium--In Context
Circulation, April 3, 2007; 115(13): 1698 - 1700.
[Full Text] [PDF]


Home page
CirculationHome page
D. J. Abrams, M. J. Earley, S. C. Sporton, P. M. Kistler, M. A. Gatzoulis, M. J. Mullen, J. A. Till, S. Cullen, F. Walker, M. D. Lowe, et al.
Comparison of Noncontact and Electroanatomic Mapping to Identify Scar and Arrhythmia Late After the Fontan Procedure
Circulation, April 3, 2007; 115(13): 1738 - 1746.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. P. Walsh and F. Cecchin
Arrhythmias in Adult Patients With Congenital Heart Disease
Circulation, January 30, 2007; 115(4): 534 - 545.
[Full Text] [PDF]


Home page
CirculationHome page
K. Yokoyama, H. Nakagawa, F. H.M. Wittkampf, J. V. Pitha, R. Lazzara, and W. M. Jackman
Comparison of Electrode Cooling Between Internal and Open Irrigation in Radiofrequency Ablation Lesion Depth and Incidence of Thrombus and Steam Pop
Circulation, January 3, 2006; 113(1): 11 - 19.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Sanders, M. Hocini, P. Jais, L.-F. Hsu, Y. Takahashi, M. Rotter, C. Scavee, J.-L. Pasquie, F. Sacher, T. Rostock, et al.
Characterization of Focal Atrial Tachycardia Using High-Density Mapping
J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2088 - 2099.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Kilicaslan, A. Verma, H. Yamaji, N. F. Marrouche, O. Wazni, J. E. Cummings, S. Hao, M. W. Andrews, S. Beheiry, A. Abdul-Karim, et al.
The need for atrial flutter ablation following pulmonary vein antrum isolation in patients with and without previous cardiac surgery
J. Am. Coll. Cardiol., March 1, 2005; 45(5): 690 - 696.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Nabar, C. Timmermans, A. Medeiros, K. Polymeropoulous, H.J.G.M. Crijns, and L.M. Rodriguez
Radiofrequency ablation of atrial arrhythmias after previous open-heart surgery
Europace, January 1, 2005; 7(1): 40 - 49.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C.-T. Tai, T.-Y. Liu, P.-C. Lee, Y.-J. Lin, M.-S. Chang, and S.-A. Chen
Non-contact mapping to guide radiofrequency ablation of atypical right atrial flutter
J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1080 - 1086.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Verma, N. F. Marrouche, N. Seshadri, R. A. Schweikert, M. Bhargava, J. D. Burkhardt, F. Kilicaslan, J. Cummings, W. Saliba, and A. Natale
Importance of ablating all potential right atrial flutter circuits in postcardiac surgery patients
J. Am. Coll. Cardiol., July 21, 2004; 44(2): 409 - 414.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. M.S. de Groot, M. J. Schalij, K. Zeppenfeld, N. A. Blom, E. T. Van der Velde, and E. E. Van der Wall
Voltage and Activation Mapping: How the Recording Technique Affects the Outcome of Catheter Ablation Procedures in Patients With Congenital Heart Disease
Circulation, October 28, 2003; 108(17): 2099 - 2106.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Committee Members, C. Blomstrom-Lundqvist, M. M. Scheinman, E. M. Aliot, J. S. Alpert, H. Calkins, A. J. Camm, W. B. Campbell, D. E. Haines, K. H. Kuck, et al.
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias --executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society
J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1493 - 1531.
[Full Text] [PDF]


Home page
CirculationHome page
C. Blomstrom-Lundqvist, M. M. Scheinman, E. M. Aliot, J. S. Alpert, H. Calkins, A. J. Camm, W. B. Campbell, D. E. Haines, K. H. Kuck, B. B. Lerman, et al.
ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias*--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)
Circulation, October 14, 2003; 108(15): 1871 - 1909.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Committee Members, C. Blomstrom-Lundqvist, M. M Scheinman, E. M Aliot, J. S Alpert, H. Calkins, A.J. Camm, W.B. Campbell, D. E Haines, K. H Kuck, et al.
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: A Report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)Developed in collaboration with NASPE-Heart Rhythm Society
Eur. Heart J., October 2, 2003; 24(20): 1857 - 1897.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Ishii, T. Nitta, S.-i. Sakamoto, S. Tanaka, and G. Asano
Incisional atrial reentrant tachycardia: experimental study on the conduction property through the isthmus
J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 254 - 262.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
S. D. Satti and L. M. Epstein
Cardiologic Interventional Therapy for Atrial and Ventricular Arrhythmias
Card. Surg. Adult, January 1, 2003; 2(2003): 1253 - 1270.
[Full Text]


Home page
Eur Heart JHome page
H. Nakagawa and W. M. Jackman
Catheter ablation of macroreentrant atrial tachycardia in patients following atriotomy
Eur. Heart J., October 2, 2002; 23(20): 1566 - 1568.
[Full Text] [PDF]


Home page
Eur Heart JHome page
W. Anne, H. van Rensburg, J. Adams, H. Ector, F. Van de Werf, and H. Heidbuchel
Ablation of post-surgical intra-atrial reentrant tachycardia. Predilection target sites and mapping approach
Eur. Heart J., October 2, 2002; 23(20): 1609 - 1616.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. M. Markowitz, R. F. Brodman, K. M. Stein, S. Mittal, D. J. Slotwiner, S. Iwai, M. K. Das, and B. B. Lerman
Lesional tachycardias related to mitral valve surgery
J. Am. Coll. Cardiol., June 19, 2002; 39(12): 1973 - 1983.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P. A Friedman
Novel mapping techniques for cardiac electrophysiology
Heart, June 1, 2002; 87(6): 575 - 582.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. B. Morton, P. Sanders, V. Deen, J. K. Vohra, and J. M. Kalman
Sensitivity and specificity of concealed entrainment for the identification of a critical isthmus in the atrium: relationship to rate, anatomic location and antidromic penetration
J. Am. Coll. Cardiol., March 6, 2002; 39(5): 896 - 906.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Ott
Dual-loop intra-atrial re-entry tachycardia in a patient with ischaemic cardiomyopathy
Europace, January 1, 2002; 4(2): 207 - 210.
[Abstract] [PDF]


Home page
CirculationHome page
Y. Yang, J. Cheng, A. Bochoeyer, M. H. Hamdan, R. C. Kowal, R. Page, R. J. Lee, P. R. Steiner, L. A. Saxon, M. D. Lesh, et al.
Atypical Right Atrial Flutter Patterns
Circulation, June 26, 2001; 103(25): 3092 - 3098.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Ouyang, S. Ernst, T. Vogtmann, M. Goya, M. Volkmer, A. Schaumann, D. Bansch, M. Antz, and K.-H. Kuck
Characterization of Reentrant Circuits in Left Atrial Macroreentrant Tachycardia: Critical Isthmus Block Can Prevent Atrial Tachycardia Recurrence
Circulation, April 23, 2002; 105(16): 1934 - 1942.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakagawa, H.
Right arrow Articles by Jackman, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakagawa, H.
Right arrow Articles by Jackman, W. M.
Related Collections
Right arrow Electrophysiology
Right arrow Ablation/ICD/surgery
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Cardiac development